Similar articles

• Factor V Leiden: a review of the literature.

  Ament L. Ament L. J Perinat Neonatal Nurs. 2003 Jul-Sep;17(3):190-5. doi: 10.1097/00005237-200307000-00004. J Perinat Neonatal Nurs. 2003. PMID: 12959480 Review.
• Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.

  Schindewolf M, Lindhoff-Last E. Schindewolf M, et al. Thromb Haemost. 2008 Apr;99(4):776-8. doi: 10.1160/TH07-10-0610. Thromb Haemost. 2008. PMID: 18392337 No abstract available.
• Homozygous factor V Leiden mutation in a woman with multiple adverse pregnancy outcomes.

  Pauer HU, Neesen J, Schloesser M, Hinney B, Rauskolb R. Pauer HU, et al. Arch Gynecol Obstet. 2000 Nov;264(3):164-5. doi: 10.1007/s004040000095. Arch Gynecol Obstet. 2000. PMID: 11129520
• Two successful pregnancies in a carrier of heterozygous factor V LEIDEN mutation with aplasia of the inferior vena cava and a history of proximal deep venous thrombosis.

  Hauck-Dlimi B, Zimmermann R, Eckstein R, Ringwald J. Hauck-Dlimi B, et al. Arch Gynecol Obstet. 2014 Jun;289(6):1375-6. doi: 10.1007/s00404-014-3183-y. Epub 2014 Feb 22. Arch Gynecol Obstet. 2014. PMID: 24563163 No abstract available.
• [Factor V Leiden mutation and pregnancy complications].

  Abraitis V, Mongirdiene A, Mockeviciene A. Abraitis V, et al. Medicina (Kaunas). 2003;39(9):823-9. Medicina (Kaunas). 2003. PMID: 14515043 Review. Lithuanian.